As of May 27
| -0.21 / -2.97%|
The 1 analysts offering 12-month price forecasts for Titan Pharmaceuticals Inc have a median target of 7.75, with a high estimate of 7.75 and a low estimate of 7.75. The median estimate represents a +12.97% increase from the last price of 6.86.
The current consensus among 1 polled investment analysts is to Buy stock in Titan Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.